# Understanding and Appraising the New Medicine Service in England

> **NCT01635361** · NA · COMPLETED · sponsor: **University of Nottingham** · enrollment: 504 (actual)

## Conditions studied

- Asthma
- Pulmonary Disease, Chronic Obstructive
- Diabetes Mellitus, Type 2
- Hypertension
- Blood Coagulation

## Interventions

- **OTHER:** New Medicine Service

## Key facts

- **NCT ID:** NCT01635361
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 504 (ACTUAL)
- **Last updated:** 2015-05-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635361, "Understanding and Appraising the New Medicine Service in England". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01635361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*